Last reviewed · How we verify
NCT06109168: MNO
Correlation of SpO2/FIO2 Ratio With PaO2/FIO2 Ratio in ARDS Patients in the ICU of H. Adam Malik Hospital
trial in Ards in 29 participants. Completed in 1 September 2023.
31 August 2023
Quick facts
| Lead sponsor | RS H Adam Malik |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 29 |
| Start date | 1 June 2023 |
| Primary completion | 31 August 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Indonesia |
Conditions studied
- Ards — all drugs for Ards →
Sponsor
RS H Adam Malik
Who can join
Adults 18 to 70, any sex, with Ards. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study to apprehend the relation of SpO2/FiO2 to PaO2/FiO2 in ARDS patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06109168
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ards
Currently open trials in the same condition.
- NCT07100860 — The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery · recruiting
- NCT06513299 — Effectiveness of Low Volume and Low Pressure in Severe Hypoxemic Patients · active not recruiting
Other RS H Adam Malik trials
Trials by the same sponsor.
- NCT06621589 — Effect of Nutritional Counseling on Health Outcomes in Female Workers Wih Obesity at Adam Malik Hospital · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06109168 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RS H Adam Malik
- Last refreshed: 15 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06109168.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing